title: Paclitaxel versus sirolimus: the battle is still ongoing.
authors.forename: Christodoulos
authors.initials: C
authors.lastname: Stefanadis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Toutouzas
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D023903:Coronary Restenosis; D054855:Drug-Eluting Stents / Q000009:adverse effects; D006801:Humans; D017239:Paclitaxel; D020123:Sirolimus; D016896:Treatment Outcome
chemical_list: D017239:Paclitaxel; D020123:Sirolimus